日本新薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2017/06/12 | 6,600 | 6,700 | 6,580 | 6,670 | +50 | +0.8% | 124,200 |
2017/06/09 | 6,630 | 6,680 | 6,580 | 6,620 | +10 | +0.2% | 207,100 |
2017/06/08 | 6,630 | 6,670 | 6,600 | 6,610 | -10 | -0.2% | 98,600 |
2017/06/07 | 6,630 | 6,670 | 6,570 | 6,620 | -40 | -0.6% | 149,700 |
2017/06/06 | 6,770 | 6,770 | 6,640 | 6,660 | -120 | -1.8% | 110,700 |
2017/06/05 | 6,670 | 6,820 | 6,650 | 6,780 | +120 | +1.8% | 195,200 |
2017/06/02 | 6,610 | 6,680 | 6,570 | 6,660 | +70 | +1.1% | 219,400 |
2017/06/01 | 6,490 | 6,610 | 6,490 | 6,590 | +130 | +2% | 139,800 |
2017/05/31 | 6,400 | 6,520 | 6,400 | 6,460 | ±0 | ±0% | 253,300 |
2017/05/30 | 6,520 | 6,520 | 6,420 | 6,460 | -10 | -0.2% | 146,900 |
2017/05/29 | 6,510 | 6,520 | 6,450 | 6,470 | -10 | -0.2% | 130,700 |
2017/05/26 | 6,510 | 6,530 | 6,460 | 6,480 | -70 | -1.1% | 196,100 |
2017/05/25 | 6,510 | 6,570 | 6,500 | 6,550 | -20 | -0.3% | 196,100 |
2017/05/24 | 6,610 | 6,630 | 6,550 | 6,570 | -40 | -0.6% | 251,800 |
2017/05/23 | 6,660 | 6,700 | 6,600 | 6,610 | +20 | +0.3% | 288,900 |
2017/05/22 | 6,680 | 6,680 | 6,570 | 6,590 | -140 | -2.1% | 249,700 |
2017/05/19 | 6,740 | 6,760 | 6,660 | 6,730 | +90 | +1.4% | 362,300 |
2017/05/18 | 6,620 | 6,700 | 6,590 | 6,640 | +20 | +0.3% | 259,800 |
2017/05/17 | 6,500 | 6,640 | 6,490 | 6,620 | +80 | +1.2% | 206,100 |
2017/05/16 | 6,540 | 6,580 | 6,480 | 6,540 | -10 | -0.2% | 198,000 |
2017/05/15 | 6,420 | 6,550 | 6,410 | 6,550 | +170 | +2.7% | 284,100 |
2017/05/12 | 6,110 | 6,400 | 6,110 | 6,380 | +120 | +1.9% | 317,700 |
2017/05/11 | 6,260 | 6,350 | 6,250 | 6,260 | -20 | -0.3% | 170,800 |
2017/05/10 | 6,260 | 6,300 | 6,190 | 6,280 | +20 | +0.3% | 273,400 |
2017/05/09 | 6,180 | 6,300 | 6,160 | 6,260 | +90 | +1.5% | 265,900 |
2017/05/08 | 6,140 | 6,200 | 6,110 | 6,170 | +100 | +1.6% | 347,100 |
2017/05/02 | 6,000 | 6,090 | 6,000 | 6,070 | +100 | +1.7% | 249,600 |
2017/05/01 | 5,940 | 5,980 | 5,920 | 5,970 | +50 | +0.8% | 213,400 |
2017/04/28 | 5,920 | 5,970 | 5,890 | 5,920 | -10 | -0.2% | 255,000 |
2017/04/27 | 5,910 | 5,960 | 5,890 | 5,930 | +60 | +1% | 341,600 |
2017/04/26 | 5,910 | 5,940 | 5,840 | 5,870 | +110 | +1.9% | 316,600 |
2017/04/25 | 5,800 | 5,810 | 5,690 | 5,760 | ±0 | ±0% | 222,600 |
2017/04/24 | 5,730 | 5,780 | 5,670 | 5,760 | +100 | +1.8% | 196,900 |
2017/04/21 | 5,630 | 5,680 | 5,590 | 5,660 | +70 | +1.3% | 202,700 |
2017/04/20 | 5,580 | 5,650 | 5,550 | 5,590 | +70 | +1.3% | 234,400 |
2017/04/19 | 5,490 | 5,610 | 5,490 | 5,520 | +50 | +0.9% | 247,200 |
2017/04/18 | 5,510 | 5,510 | 5,430 | 5,470 | -50 | -0.9% | 166,200 |
2017/04/17 | 5,460 | 5,550 | 5,460 | 5,520 | +50 | +0.9% | 151,200 |
2017/04/14 | 5,600 | 5,620 | 5,460 | 5,470 | -130 | -2.3% | 161,000 |
2017/04/13 | 5,570 | 5,630 | 5,570 | 5,600 | -30 | -0.5% | 174,100 |
2017/04/12 | 5,650 | 5,670 | 5,540 | 5,630 | -50 | -0.9% | 321,700 |
2017/04/11 | 5,670 | 5,710 | 5,660 | 5,680 | -10 | -0.2% | 191,700 |
2017/04/10 | 5,790 | 5,810 | 5,680 | 5,690 | -70 | -1.2% | 162,100 |
2017/04/07 | 5,710 | 5,820 | 5,670 | 5,760 | +100 | +1.8% | 279,600 |
2017/04/06 | 5,750 | 5,750 | 5,650 | 5,660 | -120 | -2.1% | 234,000 |
2017/04/05 | 5,700 | 5,800 | 5,700 | 5,780 | +70 | +1.2% | 218,700 |
2017/04/04 | 5,710 | 5,790 | 5,670 | 5,710 | -40 | -0.7% | 190,900 |
2017/04/03 | 5,730 | 5,800 | 5,660 | 5,750 | +80 | +1.4% | 205,800 |
2017/03/31 | 5,800 | 5,860 | 5,670 | 5,670 | -110 | -1.9% | 169,500 |
2017/03/30 | 5,850 | 5,890 | 5,770 | 5,780 | -120 | -2% | 125,100 |
1951~
2000
件表示中 / 3715件
類似銘柄と比較する
現在ご覧いただいている「日本新薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
日本新薬 | 353,400円 | +8.0% | -15.3% | 3.51% | 9.92倍 | 0.96倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
住友ファーマ | 80,400円 | -11.0% | +206.6% | 0.00% | 7.99倍 | 1.88倍 |
|
医薬品準大手、住友化学傘下。買収で米国へ展開。研究開発は精神神経、がん、再生細胞に重点 |
ツムラ | 333,200円 | +3.8% | -19.9% | 4.08% | 10.90倍 | 0.83倍 |
|
医療用漢方薬で国内シェア8割超。高齢者、がん支持療法、女性関連の3領域を重点に市場深耕 |
サンバイオ | 338,000円 | - | - | 0.00% | - | 156.55倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
ペプチド | 168,300円 | +5.0% | +1.5% | 0.00% | 14.40倍 | 3.83倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
市場注目の銘柄
チャート関連のコラム